AVISE® testing offers next-generation clinical tools for the accurate and effective diagnosis, prognosis and monitoring of autoimmune CTD. 

Our mission is to continue translating our discovery & development into real solutions that are safe, reliable and cost effective. Our current AVISE® product line encompasses six game-changing products. To learn more about each individual product, click the product name below.


A powerful diagnostic tool to help distinguish overlapping symptoms and aid in the differential diagnosis of RA, Lupus, Fibromyalgia, Sjögren's, Scleroderma, PM/DM, APS and Autoimmune Thyroid disease

AVISE® SLE Prognostic

Risk assessment testing for potential organ involvement

AVISE® Infliximab & AVISE® Adalimumab

Anti-TNF monitoring to individualize therapy & optimize dosing prior to loss of response or formation of neutralizing anti-drug antibodies


Therapeutic drug monitoring of hydroxychloroquine in whole blood


Therapeutic drug monitoring of methotrexate polyglutamates